APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,026,434 | -77.9% | 26,983 | -47.0% | 0.00% | -66.7% |
| Q2 2023 | $4,642,091 | +175.6% | 50,956 | +99.5% | 0.00% | +200.0% |
| Q1 2023 | $1,684,619 | -55.4% | 25,540 | -65.0% | 0.00% | -66.7% |
| Q4 2022 | $3,773,900 | +120.6% | 72,982 | +191.4% | 0.00% | +200.0% |
| Q3 2022 | $1,711,000 | +49.8% | 25,046 | -0.8% | 0.00% | 0.0% |
| Q2 2022 | $1,142,000 | -7.5% | 25,250 | +3.9% | 0.00% | 0.0% |
| Q1 2022 | $1,235,000 | +15.5% | 24,304 | +7.5% | 0.00% | 0.0% |
| Q4 2021 | $1,069,000 | +8.4% | 22,608 | -24.4% | 0.00% | 0.0% |
| Q3 2021 | $986,000 | -46.1% | 29,909 | +3.4% | 0.00% | 0.0% |
| Q2 2021 | $1,828,000 | +43.8% | 28,937 | -2.3% | 0.00% | 0.0% |
| Q1 2021 | $1,271,000 | -27.9% | 29,609 | -3.9% | 0.00% | 0.0% |
| Q4 2020 | $1,763,000 | +133.8% | 30,824 | +23.3% | 0.00% | 0.0% |
| Q3 2020 | $754,000 | -11.7% | 24,992 | -4.4% | 0.00% | 0.0% |
| Q2 2020 | $854,000 | +231.0% | 26,144 | +171.9% | 0.00% | – |
| Q1 2020 | $258,000 | -9.5% | 9,616 | +3.4% | 0.00% | – |
| Q4 2019 | $285,000 | +35.1% | 9,298 | +6.1% | 0.00% | – |
| Q3 2019 | $211,000 | -3.7% | 8,767 | +1.4% | 0.00% | – |
| Q2 2019 | $219,000 | – | 8,647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |